ImageneBio, Inc.
IMA
$5.83
-$0.19-3.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 800.00K | 800.00K | 4.30M | 4.30M | 3.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 800.00K | 800.00K | 4.30M | 4.30M | 3.50M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 800.00K | 800.00K | 4.30M | 4.30M | 3.50M |
| SG&A Expenses | 20.73M | 17.88M | 8.49M | 8.70M | 8.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.25M | 46.89M | 25.83M | 24.86M | 40.50M |
| Operating Income | -48.45M | -46.09M | -21.53M | -20.56M | -37.00M |
| Income Before Tax | -45.70M | -43.31M | -21.64M | -20.32M | -36.56M |
| Income Tax Expenses | -350.00K | -61.00K | 13.00K | 13.00K | 13.00K |
| Earnings from Continuing Operations | -45.35 | -43.25 | -21.66 | -20.33 | -36.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.35M | -43.25M | -21.66M | -20.33M | -36.57M |
| EBIT | -48.45M | -46.09M | -21.53M | -20.56M | -37.00M |
| EBITDA | -48.05M | -46.07M | -21.44M | -20.02M | -35.86M |
| EPS Basic | -11.30 | -12.09 | -13.50 | -5.97 | -6.03 |
| Normalized Basic EPS | -5.62 | -5.74 | -5.34 | -1.99 | -2.02 |
| EPS Diluted | -11.30 | -12.09 | -13.50 | -5.97 | -6.03 |
| Normalized Diluted EPS | -5.62 | -5.74 | -5.34 | -1.99 | -2.02 |
| Average Basic Shares Outstanding | 482.37M | 477.46M | 470.33M | 468.92M | 328.26M |
| Average Diluted Shares Outstanding | 482.37M | 477.46M | 470.33M | 790.39M | 649.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |